Found: 9
Select item for more details and to access through your institution.
Applications of Bayesian statistical methodology to clinical trial design: A case study of a phase 2 trial with an interim futility assessment in patients with knee osteoarthritis.
- Published in:
- Pharmaceutical Statistics, 2019, v. 18, n. 1, p. 39, doi. 10.1002/pst.1906
- By:
- Publication type:
- Article
Evaluation of the Renal Effects of an Antisense Phosphorothioate Oligodeoxynucleotide in Monkeys.
- Published in:
- Toxicologic Pathology, 1999, v. 27, n. 3, p. 307, doi. 10.1177/019262339902700306
- By:
- Publication type:
- Article
Synthetic Oligonucleotides: The Development of Antisense Therapeutics.
- Published in:
- Toxicologic Pathology, 1999, v. 27, n. 1, p. 8, doi. 10.1177/019262339902700103
- By:
- Publication type:
- Article
Regional deposition of mometasone furoate nasal spray suspension in humans.
- Published in:
- Allergy & Asthma Proceedings, 2015, v. 36, n. 1, p. 48, doi. 10.2500/aap.2015.36.3817
- By:
- Publication type:
- Article
Characterization of Oligonucleotide Metabolism In Vivo via Liquid Chromatography/Electrospray Tandem Mass Spectrometry with a Quadrupole Ion Trap Mass Spectrometer.
- Published in:
- Journal of Mass Spectrometry, 1997, v. 32, n. 3, p. 305, doi. 10.1002/(SICI)1096-9888(199703)32:3<305::AID-JMS482>3.0.CO;2-R
- By:
- Publication type:
- Article
Therapeutic suppression of translation initiation factor eIF4E expression reduces tumor growth without toxicity.
- Published in:
- Journal of Clinical Investigation, 2007, v. 117, n. 9, p. 2638, doi. 10.1172/JCI32044
- By:
- Publication type:
- Article
Hepatic and glucagon-like peptide-1--mediated reversal of diabetes by glucagon receptor antisense oligonucleotide inhibitors.
- Published in:
- Journal of Clinical Investigation, 2004, v. 113, n. 11, p. 1571, doi. 10.1172/JCI200420911
- By:
- Publication type:
- Article
The Management of Family Firms: An Empirical Investigation.
- Published in:
- International Small Business Journal: Researching Entrepreneurship, 1995, v. 13, n. 4, p. 11, doi. 10.1177/026624269501300402
- By:
- Publication type:
- Article
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the CGRP Binding Monoclonal Antibody LY2951742 (Galcanezumab) in Healthy Volunteers.
- Published in:
- Frontiers in Pharmacology, 2017, p. 1, doi. 10.3389/fphar.2017.00740
- By:
- Publication type:
- Article